Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05768815
Other study ID # H-02-23-8940
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 28, 2023
Est. completion date December 2026

Study information

Verified date March 2024
Source University of Ottawa
Contact Nicole Racine, PhD, C.Psych
Phone 403-992-7869
Email nracine2@uottawa.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the effectiveness of the Breaking the Cycle (BTC) and Maxxine Wright (MW) programs in substance-involved mothers and their children. One key difference between the two programs is that the BTC program contains an infant mental health component while the MW program primarily focuses on the mothers. The main questions the trial aims to answer are: - Do children at BTC demonstrate enhanced infant mental health compared to children at MW up to 2 years post-intervention? - Do mother-child dyads at BTC experience more decreases in child adverse childhood experiences (ACE), maternal stress, and mental health symptoms and have better home environment scores, parenting attitudes, and mother-child relationship scores compared to mother-child dyads at MW? - Are enhanced infant mental health outcomes associated with children's lower psychosocial risk scores and mothers with lower ACE scores, lower depression and anxiety scores, and lower maternal stress? - Are the associations between treatment dose and infant mental health scores mediated by parenting attitudes and the mother-child relationship? Does child exposure to psychosocial risk moderate the association between treatment dose and child outcomes? - How do the mechanisms of change lead to the effectiveness of BTC? What are the potential lifetime health and non-health outcomes of at-risk children at BTC? What is the long-term social return on investment (SROI) of BTC? Participants will complete several questionnaires at three timepoints while receiving services at either BTC or MW: during the intake phase, 12 months after their engagement in services and 24 months after their engagement in services. Given that the two programs serve a similar demographic of women, researchers will compare the BTC group and the MW group to establish the comparative effectiveness and mechanisms of change of the infant mental health component of BTC.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2026
Est. primary completion date September 2026
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - receiving services at either BTC or MW - having a child under the age of 6 years - being able to answer a questionnaire in English Exclusion Criteria: -

Study Design


Intervention

Behavioral:
Breaking the Cycle Program
BTC is a prevention and early intervention program in Toronto, Canada, serving substance-using pregnant and/or parenting women with children under six years of age. Established by the Canadian Mothercraft Society in 1995, BTC is funded by the Community Action Program for Children and the Canadian Prenatal Nutrition Program through the Public Health Agency of Canada. BTC provides three program components that act synergistically: a) individualized services for mothers, b) individualized services for children, and c) relational interventions that enhance the mother-child relationship and promote infant mental health. Coordinated supports are offered through formal partnerships across service sectors. In 2004, BTC was recognized by the United Nations as an exemplary program serving pregnant and parenting women with substance use problems, and their young children.
Maxxine Wright Program
Founded in 2005 and located in Surrey, British Columbia, the Maxxine Wright Community Health Centre (MWCHC) supports women who are pregnant and/or have young children and are impacted by substance use and/or violence. Women do not need to have children in their care to receive services. The program is funded and operated by the Fraser Health Authority, with additional in-kind support from the BC Ministry for Children and Family Development and the BC Ministry of Social Development and Poverty Reduction. MW addresses maternal substance use and exposure to violence through women-centered, trauma-informed, culturally grounded, and interdisciplinary approaches. Primary services offered include addiction counselling, primary health care, and group therapy to address interpersonal violence. Within MW, child-focused services are limited to primary health (e.g., well baby checks, childcare).

Locations

Country Name City State
Canada Maxxine Wright Community Health Centre Surrey British Columbia
Canada Mothercraft, Breaking the Cycle Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University of Ottawa

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Children's socio-emotional functioning will be measured using the Ages and Stages Questionnaire-Social Emotional (ASQ-SE-2) The ASQ-SE-2 is a 26-item, parent-completed questionnaire that is highly reliable and focuses solely on social-emotional development in young children aged 1-72 months. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Primary Children's developmental functioning will be measured using the Ages and Stages Questionnaire-Third Edition (ASQ-3) The ASQ-3 consists of a series of parent-completed questionnaires to assess child development across ?ve domains for children 1 to 66 months: communication, gross motor, ?ne motor, problem-solving, and personal-social skills. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Children's exposure to risk and protective factors will be measured using a cumulative risk measure (Bondi et al., 2020) This cumulative risk measure is designed to identify risk and protective factors for children of substance-involved mothers. It will be used to assess children's exposure to risk (e.g., ACEs, poverty, maternal mental illness) and protective factors (e.g., family social support, childcare, community supports). Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Sensitivity of maternal behaviour will be measured using the Maternal Behavior Q-Sort (MBQS) Brief Version The MBQS Brief Version is composed of 25 items and will be used by researchers to assess the sensitivity of maternal behaviour from a 10-minute in vivo mother-child interaction. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Maternal stress will be measured using the Parenting Stress Index Short Form (PSI-4-SF) The PSI-4-SF consists of 36 items. All domains (Parent Distress, Dif?cult Child, and Parent-Child Dysfunctional Interaction) and the Total Stress Scale have acceptable reliability and validity. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Parenting attitudes will be measured using the Adult-Adolescent Parenting Inventory Version 2.0 (AAPI-2) The AAPI-2 is composed of 40 items and will be used to assess parenting attitudes related to expectations, empathy, and discipline. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Self-efficacy and satisfaction as a parent will be measured using the Being a Parent Scale The Being a Parent Scale consists of 16 items. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Quality and quantity of stimulation available to the child will be measured using the Home Observation for Measurement of the Environment Inventory (HOME) The HOME is a 45-item questionnaire designed to measure the quality and quantity of stimulation available to young children. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Maternal depression will be measured using the Center for Epidemiological Studies Depression Scale (CES-D) The CES-D consists of 20 items. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Maternal anxiety will be measured using the Beck Anxiety Inventory (BAI) The BAI consists of 21 items. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Maternal adverse childhood experiences (ACEs) will be measured using a Maternal ACEs Measure (Felitti et al., 1998; Dube et al., 2003) This 10-item questionnaire requires mothers to retrospectively report on their ACEs prior to 18 years of age. The questions pertain to abuse, neglect, and household dysfunction. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Maternal anxiety will be measured using the Generalized Anxiety Disorder Scale (GAD-7) The GAD-7 consists of 7 items. Change from pre-intervention to 12 months after engagement and 24 months after engagement
Secondary Maternal depression will be measured using the Patient Health Questionnaire-9 (PHQ-9) The PHQ-9 consists of 9 items. Change from pre-intervention to 12 months after engagement and 24 months after engagement
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05806840 - Rapid Adaptation to Prevent Drug Use N/A
Recruiting NCT06003725 - Cultural Adaptation of Drug Treatment for DJJ Youth N/A
Recruiting NCT05414344 - A Brief Intervention for Alcohol Users With Interpersonal Trauma N/A
Completed NCT05606601 - An Online Intervention Addressing Mental Health and Substance Use in University Students N/A
Completed NCT03489434 - Technology-Based Prevention for Adolescents in Primary Care N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT02990026 - Specialty Mental Health Probation in North Carolina N/A
Not yet recruiting NCT06116266 - Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care) N/A
Not yet recruiting NCT03249428 - E-Cigarette Inner City RCT N/A
Active, not recruiting NCT03129334 - Preventing Prescription Drug Abuse in Middle School Students N/A
Completed NCT04183400 - Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness N/A
Completed NCT02112201 - The ProGirls Study N/A
Completed NCT01752998 - Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings N/A
Terminated NCT01661517 - Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting Phase 0
Completed NCT01351454 - Behavioral Depression Treatment for African American HIV-infected Substance Users N/A
Completed NCT01511380 - Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth Phase 2
Completed NCT01154309 - Group CBT for Depression and AOD Disorders Phase 1
Completed NCT01025674 - Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8 N/A
Completed NCT00996541 - Support To Reunite Involve and Value Each Other N/A